ELEVECTA™ Cell Lines

Enhance your gene therapy efforts with a comprehensive range of cell lines designed for adeno-associated virus (AAV) production.

As viral vector manufacturing advances, adopting a more strategic approach is crucial. This begins with selecting the optimal cell line. Cytiva's ELEVECTA™ cell line portfolio features cutting-edge design and extensive expertise, offering transient, packaging, and producer solutions that ensure high-quality therapeutic AAVs and adaptability to changing needs. United by a shared parental cell line, these three options form a complete portfolio, ensuring regulatory and quality uniformity.